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Introduction
Accurate chromosome segregation is essential for cell viability, 
organismal development, and tumor suppression. Accordingly, 
eukaryotes have evolved several mechanisms to defend against 
chromosome segregation errors. Paramount among these is the 
so-called spindle assembly checkpoint (SAC), which inhibits 
anaphase onset until all kinetochore pairs have attached to 
microtubules (MTs) emanating from both spindle poles, gener-
ating a stable configuration termed chromosome biorientation 
(for review see Musacchio and Salmon, 2007). In biochemical 
terms, the SAC acts by inhibiting the Cdc20-bound form of 
the anaphase-promoting complex/cyclosome (APC/C), a large 
ubiquitin protein ligase (Peters, 2006). Repression of APC/C
Cdc20 
activity stabilizes its downstream targets including securin and 
cyclin B, which directly block sister chromatid separation and 
mitotic exit.
Early time-lapse and laser ablation studies pointed to a 
central role for unattached kinetochores in checkpoint signaling 
(Rieder et al., 1994, 1995; Li and Nicklas, 1995). Consistent 
with this notion, all known SAC transducers, including the   
protein kinases Mps1, Bub1, and BubR1 and the nonkinase 
components Mad1, Mad2, and Bub3, associate with unattached 
kinetochores in prometaphase (for review see Musacchio and 
Salmon,  2007).  In  particular,  it  is  thought  that  kinetochore- 
localized Mad1/Mad2 heterodimers catalyze the conversion of 
soluble open Mad2 (O-Mad2) to a closed conformer (C-Mad2) 
that stably binds to and inhibits Cdc20 (De Antoni et al., 2005). 
However, other compelling data argue that SAC signaling does 
not entirely depend on kinetochores. First, complexes of Cdc20 
bound to Mad2 and/or BubR1 (sometimes referred to as the   
mitotic checkpoint complex) have been detected in interphase 
mammalian cells and yeast strains that lack functional kineto-
chores (Fraschini et al., 2001; Sudakin et al., 2001). Second, 
Mad2 and BubR1 are required not only to prolong mitosis in the 
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uses  cytosolic  and  kinetochore-based  signaling 
pathways to inhibit anaphase. In this study, we use 
chemical genetics to show that the protein kinase Mps1 
regulates  both  aspects  of  the  SAC.  Human  MPS1-null 
cells were generated via gene targeting and reconstituted 
with either the wild-type kinase (Mps1
wt) or a mutant ver-
sion (Mps1
as) sensitized to bulky purine analogues. Mps1 
inhibition sharply accelerated anaphase onset, such that 
cells completed mitosis in 12 min, and prevented Cdc20’s 
association with either Mad2 or BubR1 during interphase, 
i.e., before the appearance of functional kinetochores. 
Furthermore, intramitotic Mps1 inhibition evicted Bub1 
and all other known SAC transducers from the outer   
kinetochore, but contrary to a recent study, did not perturb 
aurora B–dependent phosphorylation. We conclude that 
Mps1 has two complementary roles in SAC regulation: 
(1) initial cytoplasmic activation of Cdc20 inhibitors and 
(2)  recruitment  of  factors  that  promote  sustained  ana-
phase inhibition and chromosome biorientation to un-
attached kinetochores.
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Results
Chemical genetics reveals the M phase–
timing function of Mps1
To establish a tight genetic background for functional experi-
ments, we used adeno-associated virus (AAV)–mediated gene 
targeting (Berdougo et al., 2009) to conditionally delete MPS1 
from the human genome. In brief, two vectors were constructed, 
such that exon 4 of the MPS1 locus was either flanked by loxP 
sites or deleted outright (Fig. 1 A). Conceptually, removal of 
this exon truncates the open reading frame at codon 121, up-
stream of sequences required for kinase activity and kinetochore 
localization (Stucke et al., 2004). Both vectors were used to se-
quentially infect human telomerase reverse transcriptase (hTERT)–
immortalized retinal pigment epithelial (RPE) cells with targeting 
efficiencies of 6% and 3%, respectively. To initiate gene deletion, 
presence of unattached kinetochores, but also to specify the mini-
mum length of M phase under unperturbed conditions (Meraldi 
et al., 2004). In contrast, inactivation of other SAC components 
or factors required for kinetochore–MT binding does not accel-
erate M phase. Third, BubR1’s essential mitotic functions can 
be reconstituted with an N-terminal fragment that binds Cdc20 
but cannot localize to kinetochores (Malureanu et al., 2009). 
Together, these observations argue that Mad2 and BubR1 are 
components of a cytosolic timer that actively restrains anaphase 
onset, affording early mitotic cells time to mature their kineto-
chores  and  (if  necessary)  engage  the  kinetochore-dependent 
branch of the SAC. However, the upstream factors that govern 
this timer remain elusive.
Although the SAC is conserved throughout Eukarya, 
efforts to define the order in which its components act relative 
to one another have yielded unexpectedly divergent results. For 
instance, studies in human cells have consistently positioned 
Mps1 near the distal end of the SAC, as depleting this kinase via 
RNAi results in the selective loss of Mad2 from kinetochores 
(Stucke et al., 2002; Liu et al., 2003, 2006; Jelluma et al., 2008; 
Tighe et al., 2008). In contrast, genetic analyses in yeast and 
immunodepletion experiments in Xenopus laevis egg extracts 
place Mps1 at the apex of the SAC, upstream of not only Mad2 
but also Bub1, BubR1/Mad3, and Mad1 (Hardwick et al., 1996; 
Abrieu et al., 2001; Vigneron et al., 2004; Wong and Fang, 
2005). Similarly, although human Mps1 reportedly facilitates 
chromosome alignment by direct phosphorylation of the aurora B 
kinase regulator borealin, and thus is necessary to sustain 
full aurora B activity in human cells (Jelluma et al., 2008), the 
aurora B–related kinase Ipl1 retains its normal localization and full 
activity in Mps1-deficient yeast strains (Maure et al., 2007). 
These findings have been interpreted as evidence of species-
specific differences in kinetochore organization and SAC regu-
lation, but other explanations (e.g., technical issues related to 
the completeness or specificity of Mps1 inactivation) have not 
been excluded.
To clarify these issues, we created human cells in which 
both copies of the MPS1 locus could be deleted via gene target-
ing. The resulting MPS1-null cells were complemented with 
versions of the kinase that differ at a single amino acid within 
the ATP-binding site, conferring resistance or sensitivity to 
bulky purine analogues. Using this chemical genetic system, we 
investigated the role of Mps1 in M phase progression and SAC 
signaling. Our experiments identify a novel interphase func-
tion for Mps1, whereby it ensures that Cdc20 binds Mad2 and 
BubR1 before kinetochores have matured and can generate their 
own anaphase inhibitory signals. Mps1 is also critical for the 
subsequent phase of SAC signaling, as its inhibition evicts all 
known SAC mediators from prometaphase kinetochores. Further-
more, we find that although human Mps1 indeed controls chro-
mosome biorientation, it does so independently of aurora B 
regulation, as indicated by undiminished phosphorylation of 
multiple aurora B substrates in Mps1-inhibited cells. Collec-
tively, these findings reveal new insights into the SAC response 
in mammalian cells and provide new tools for interrogating this 
response in a rapid and specific manner without collateral inhi-
bition of aurora B.
Figure  1.  Generation  of  Mps1  conditional–null  and  analogue-sensitive 
human  cells.  (A)  Schematic  of  AAV  vectors  used  to  mutate  the  MPS1  
locus. Circles and triangles denote FRT and loxP sites, respectively. ITR, 
inverted terminal repeat. (B) MPS1
flox/ cells were infected with the indi-
cated adenoviruses and analyzed for Mps1 expression by immunoblotting.   
(C) MPS1
flox/ and MPS1
/ cells complemented by wild-type (wt) or ana-
logue-sensitive (as) Mps1 transgenes were analyzed by immunoblotting. LAP, 
localization and affinity purification. (D) Allele-specific inhibition of Mps1
as. 
Cells were cultured in the presence of the bulky purine analogue 3MB-PP1 
(from left to right: 0, 0.078, 0.313, 1.25, and 5 µM) for 7 d and stained 
with crystal violet. (E) Cells were fixed and stained with antibodies to 
centromere autoantigens (CREST; red) and transgene-encoded Mps1
wt and 
Mps1
as (green). Bar, 10 µm. (F) Mps1
as inhibition overrides the SAC. Cells 
were filmed at 10-min intervals during treatment with nocodazole in the 
presence or absence of 10 µM 3MB-PP1 to assess the length of M phase 
(defined as the period of cell rounding by phase-contrast microscopy).   
Error bars indicate SEM.91 Mps1 assembles Cdc20 inhibitory complexes • Maciejowski et al.
spindle  poisons  that  either  globally  depolymerize  MTs  (no-
codazole) or prevent spindle bipolarization by targeting the kine-
sin Eg5 (monastrol and S-trityl-l-cysteine [STLC]). Afterward, 
mitotic indices were determined by MPM-2 staining and flow 
cytometry (Fig. S1). In the absence of 3MB-PP1, cells of all 
genotypes arrested with comparably high efficiencies. However, 
in the presence of 3MB-PP1, Mps1
as cells demonstrated little if 
any increase in the mitotic index relative to unchallenged controls.   
To complement this endpoint assay, we measured the duration of 
M  phase  in  individual  nocodazole-treated  cells  by  time-lapse 
phase-contrast microscopy. Strikingly, Mps1
as inhibition reduced 
the length of M phase (defined in this assay as the period of cell 
rounding) from 1,651 ± 463 min to 18 ± 12 min (Fig. 1 F).
Acceleration of M phase to this degree was noteworthy 
and unexpected, as both wild-type cells and those lacking the 
kinetochore-dependent arm of the SAC require 30 min to 
complete mitosis (Meraldi et al., 2004). To score mitotic timing 
more precisely, we generated cells expressing a histone H2B–
mCherry fusion protein and imaged them at higher temporal 
and spatial resolution using spinning-disk confocal microscopy 
(Fig.  2  A).  Mps1
wt  cells  progressed  from  nuclear  envelope 
MPS1
flox/ cells were infected with adenoviruses expressing Cre 
recombinase (AdCre) or -galactosidase (Adgal) as a negative 
control. Mps1 expression ceased within 48 h of AdCre infection 
without  the  appearance  of  any  new  immunoreactive  species 
(Fig. 1 B). As anticipated, MPS1
/ clones could not be recov-
ered by limiting dilution (unpublished data), indicating that this 
kinase is essential in mammals.
Next,  MPS1
flox/  cells  were  transduced  with  retroviruses   
expressing either the wild-type kinase (Mps1
wt) or an analogue-
sensitive mutant (M602A; hereafter Mps1
as) fused to a localization 
and affinity purification tag (Cheeseman and Desai, 2005). In vitro 
Mps1
as was considerably less active than Mps1
wt, which is similar 
to other analogue-sensitive kinases (Fig. S1; Bishop et al., 2000; 
Jones et al., 2005; Burkard et al., 2007; Holland et al., 2010).   
Nevertheless, both Mps1
as and Mps1
wt supported the growth of 
MPS1-null cells (Fig. 1, C and D) and localized to kinetochores 
(Fig. 1 E), demonstrating their functionality in vivo. Crucially,   
Mps1
as cells alone were susceptible to growth inhibition by the 
bulky purine analogue 3MB-PP1 (Fig. 1 D; Burkard et al., 2007).
To evaluate the integrity of these alleles with respect to 
SAC signaling, Mps1
wt and Mps1
as cells were challenged with 
Figure 2.  Mps1 is a component of the M phase timer. (A) Mps1
wt and Mps1
as cells stably expressing mCherry-tagged histone H2B were treated with   
10 µM 3MB-PP1 and filmed at 1-min intervals by spinning-disk confocal microscopy. Maximum intensity projections are shown (Videos 1–6). Bar, 10 µm. 
(B) Quantification of the mitotic timing defect in Mps1-inhibited cells. Cumulative frequency of anaphase onset is plotted as a function of time after NEB.   
(C) Strong aurora B inhibition does not block the autophosphorylation of Mps1. HEK293 cells were transfected with GFP-tagged Mps1 expression plas-
mids, arrested in M phase with nocodazole (noc), and treated with or without 2 µM ZM for 2 h. Cell extracts were resolved by SDS-PAGE and probed with 
antibodies to serine 10–phosphorylated histone H3 (to confirm suppression of aurora B kinase activity) and GFP (to assess Mps1’s electrophoretic mobility, 
which becomes retarded by its mitotic activation and autophosphorylation; Stucke et al., 2004).JCB • VOLUME 190 • NUMBER 1 • 2010   92
Cdc20 to dissociate from Mad2 and BubR1, whereas its associa-
tion with the APC/C was only mildly affected (Fig. 3 A). In con-
trast, ZM treatment failed to disrupt these interphase complexes 
(Fig. 3 B) in keeping with its inability to accelerate mitotic timing 
(Fig. 2 B). Importantly, the APC8 and BubR1 polypeptides ana-
lyzed  in  these  experiments  lacked  mitotic  phosphorylation- 
induced mobility shifts (Fig. 3 C; Kraft et al., 2003; Elowe et al., 
2007; Lénárt et al., 2007), confirming that Mps1 regulates their 
interaction with Cdc20 specifically during interphase.
Recent evidence indicates that BubR1 binding to Cdc20 is 
required to prevent premature turnover of APC/C
Cdc20 substrates 
in early mitotic cells (Malureanu et al., 2009). Consistent with 
its effect on this interaction, Mps1 inhibition reduced the abun-
dance of two well-characterized APC/C
Cdc20 substrates, securin 
and cyclin B, during prophase (Fig. 4 A). This decrease was 
attributable to proteasome-mediated turnover, as it was fully 
suppressed by MG132 treatment (Fig. 4 B). We conclude that 
by promoting the formation of Cdc20 inhibitory complexes, 
Mps1 protects cyclin B and securin from degradation in early 
mitosis and thus guards against premature anaphase onset.
To extend these results, we tested whether Mps1 also con-
trols the assembly of Cdc20 inhibitory complexes during mitosis. 
In brief, Mps1
wt and Mps1
as cells were treated overnight with 
STLC and collected by shake off. Each population of pure (>95%) 
mitotic cells was transferred to medium containing STLC, 3MB-
PP1, and/or MG132. After 2 h, cells were analyzed by Cdc20 
immunoprecipitation (IP) and quantitative immunoblotting.   
Intramitotic Mps1 inhibition dissociated Mad2 and BubR1 from 
Cdc20 (Fig. 5, A and B). In contrast, Mad2’s interaction with its 
kinetochore receptor Mad1 was unaffected (Fig. 5 B). In the ab-
sence of MG132, intramitotic Mps1 inhibition resulted in rapid 
destruction of cyclin B and M phase exit (Fig. 5 C). We conclude 
that Mps1 activity is continuously required for the assembly of 
Cdc20 inhibitory complexes during interphase and mitosis.
breakdown (NEB) to anaphase in 34 ± 19 min, whereas un-
treated Mps1
as cells exhibited slightly longer kinetics of 42 ± 
26 min (Fig. 2 B). However, upon 3MB-PP1 treatment, the NEB 
to anaphase interval in Mps1
as cells fell to just 12 ± 2 min, as also 
occurs in Mad2- or BubR1-depleted HeLa cells (Meraldi et al., 
2004). Because Mps1 is thought to regulate aurora B (Jelluma 
et al., 2008), we tested whether the latter is also required to 
sustain normal M phase timing. However, treating cells with the 
aurora kinase inhibitor ZM447439 (hereafter ZM; Ditchfield 
et al., 2003) actually delayed anaphase onset slightly rather than 
accelerating it (Fig. 2 B). Aurora B inhibition also failed to block 
Mps1’s self-catalyzed phosphorylation and consequent upshift 
on SDS-PAGE (Fig. 2 C). We conclude that Mps1 plays a key 
role in setting the basal length of mitosis but does so by a mech-
anism that is independent of aurora B.
Mps1 is continuously required for the 
assembly of Cdc20 inhibitory complexes 
during interphase and mitosis
M phase timing is known to depend on Mad2 and BubR1 but not 
on other SAC components or mediators of kinetochore–MT 
attachment (Meraldi et al., 2004). Both Mad2 and BubR1 bind to 
Cdc20 either simultaneously (Sudakin et al., 2001; Herzog et al., 
2009)  or  separately  (Tang  et  al.,  2001;  Nilsson  et  al.,  2008;   
Kulukian et al., 2009) and inhibit APC/C
Cdc20-mediated ubiquity-
lation. Notably, Cdc20 inhibitory complexes are present during 
interphase (Sudakin et al., 2001; Tang et al., 2001; Malureanu   
et al., 2009) before either MT-binding proteins or SAC transducers 
have been targeted to centromeres (Cheeseman and Desai, 2008). 
To probe Mps1’s role in the formation of such complexes, asyn-
chronous Mps1
wt and Mps1
as cultures were treated with 3MB-
PP1 for 2 h and depleted of mitotic cells by shake off, after which 
Cdc20 and associated proteins were immunoprecipitated and   
analyzed by quantitative immunoblotting. Mps1 inhibition caused 
Figure  3.  Mps1  directs  the  assembly  of 
Cdc20  inhibitory  complexes  in  interphase.  
(A) Mps1
wt and Mps1
as cells were treated with 
3MB-PP1 for 2 h. Extracts were immunoprecip-
itated with antibodies to Cdc20 and resolved 
by SDS-PAGE. Levels of BubR1, APC8, Mad2, 
and Cdc20 in each IP were determined by 
quantitative immunoblotting. The ratio of each 
protein to Cdc20 was computed and normal-
ized to ratios obtained from untreated Mps1
wt 
cells  (=  1.0).  (B)  Mps1
wt  cells  were  treated 
with ZM for 2 h and processed as in A. White 
line indicates that intervening lanes have been 
spliced out. (C) Interphase and mitotic Cdc20 
IPs  were  electrophoresed  on  6%  gels  to  re-
solve  mitotically  phosphorylated  APC8  (left) 
and  BubR1  (right)  polypeptides  as  distinct 
species. Numbers at the bottom are loading 
amounts. Black lines indicate that intervening 
lanes have been spliced out. ctrl, control. Error 
bars indicate SEM.93 Mps1 assembles Cdc20 inhibitory complexes • Maciejowski et al.
failed to suppress the phosphorylation of either aurora B sub-
strate.  To  corroborate  these  results,  we  examined  CENP-A 
phosphorylation levels in MPS1-null cells and again detected 
no significant loss of phosphorylation (Fig. 6 E). These results 
have two important implications: (1) Mps1 promotes metaphase 
chromosome alignment independently of aurora B, and (2) Mps1 
inhibition can be used to interrogate the SAC without collateral 
suppression of aurora B–dependent phosphorylation.
Mps1 recruits Bub1 and all other SAC 
transducers to the outer kinetochore  
and is necessary for centromeric  
targeting of shugoshin
To investigate why chromosomes misalign despite normal phos-
phorylation of aurora B substrates, we examined known regula-
tors of SAC signaling, kinetochore–MT attachment, and error 
Mps1 promotes chromosome alignment 
independently of aurora B
In addition to restraining anaphase onset, Mps1 is necessary 
for alignment of sister chromatids at the metaphase plate, a func-
tion that has been attributed to Mps1-dependent activation of 
aurora B (Jelluma et al., 2008). In an attempt to confirm this 
finding, we treated Mps1
wt and Mps1
as cells with 3MB-PP1 and 
MG132 to analyze chromosome alignment while blocking ana-
phase onset. Although almost all cells with active Mps1 had 
well-formed metaphase plates, 47% of Mps1-inhibited cells 
had misaligned chromosomes near one or both spindle poles   
as well as broader than normal metaphase plates (Fig. 6 A).   
In parallel, we measured levels of phosphorylated histone H3 and 
centromere protein A (CENP-A) via quantitative immunoblot-
ting and fluorescence microscopy with phosphospecific antibodies 
(Fig. 6, B–D). Surprisingly, allele-specific Mps1 inhibition 
Figure  4.  Mps1  protects  cyclin  B  and  se-
curin  from  premature  destruction.  (A)  Cells 
of the indicated genotypes were treated with 
or without 3MB-PP1, fixed, and stained with 
antibodies  to  serine  10–phosphorylated  his-
tone H3 (pH3) and securin (left) or cyclin B 
(right). Nuclei were counterstained with DAPI. 
Prophase cells were identified by their uniform 
pH3 staining (Hendzel et al., 1997), partially 
condensed chromatin (left), and nuclear import 
of cyclin B (right; Hagting et al., 1999). Note 
that cyclin B staining used methanol fixation, 
which preserves chromatin condensation less 
well  than  aldehyde  fixation.  (B)  Cells  were 
treated with both 3MB-PP1 and MG132 for 
2 h and analyzed as in A. Asterisks indicate 
statistically significant deviation (P < 0.01 by 
one-way  analysis  of  variance)  from  Mps1
wt 
cells treated with 3MB-PP1. Error bars indicate 
SEM. Bars, 10 µm.JCB • VOLUME 190 • NUMBER 1 • 2010   94
Mps1 regulates Bub1 spatially and functionally, providing a 
simple explanation for the chromosome biorientation defects of 
Mps1-inhibited cells, which occurred despite normal levels of 
aurora B–catalyzed phosphorylation.
Cytosol-specific rescue of Mps1 inhibition 
restores mitotic timing and SAC 
proficiency to human cells
Both Mad2 and BubR1 can inhibit APC/C
Cdc20 and regulate   
the  timing  of  anaphase  onset  independently  of  kinetochores 
(Meraldi et al., 2004; Malureanu et al., 2009). To determine 
whether the same is true for Mps1, we exploited the fact that 
Mps1’s association with kinetochores depends on its N termi-
nus (Liu et al., 2003; Stucke et al., 2004). In brief, we con-
structed  a  mutant  allele  lacking  the  first  100  amino  acids 
(hereafter referred to as Mps1
N) that indeed fails to localize to 
kinetochores (Fig. 8 A). Both Mps1
N and Mps1
wt were intro-
duced into Mps1
as cells as mCherry fusions, generating Mps1
as/N  
and Mps1
as/wt cells. These cells were treated with 3MB-PP1   
to inactivate Mps1
as and probe the functionality of the remaining 
allele. This assay revealed that Mps1 localization is crucial for 
correction in Mps1-inhibited cells using quantitative microscopy 
(Fig. 7). Remarkably, all SAC transducers tested, including 
Bub1, BubR1, Mad1, Mad2, and Zw10, were evicted after Mps1 
inhibition (Fig. 7 and Fig. S2). Also lost were CENP-E and Plk1, 
which are important stabilizers of kinetochore–MT attachment 
(Fig. S2). In contrast, core MT-binding factors such as Ndc80 
and human KNL1 (also called AF15q14, blinkin, or CASC5) re-
mained tightly bound at the kinetochore, as did Mps1 itself (Fig. 7). 
Similarly, aurora B and INCENP were properly localized at the 
inner centromere (Fig. S2), which is consistent with the intact 
phosphorylation of CENP-A in these cells (Fig. 6).
This spectrum of kinetochore targeting defects parallels 
the known consequences of Bub1 inactivation in both mamma-
lian cells and frog egg extracts (Sharp-Baker and Chen, 2001; 
Johnson et al., 2004; Perera et al., 2007). In addition to regulat-
ing  the  SAC,  Bub1  facilitates  pericentromeric  cohesion  by 
phosphorylating histone H2A on threonine 120, which in turn 
recruits the cohesin protector Sgo1 (Kawashima et al., 2010). 
Interestingly, inactivating Mps1 hindered T120 phosphoryla-
tion at centromeres, causing Sgo1 to spread out onto chromo-
some arms (Fig. S3). Together, these findings demonstrate that 
Figure 5.  Mps1 continuously stabilizes Cdc20 inhibitory complexes in M phase. (A) Mitotic cells were harvested by STLC treatment and shake off and 
incubated in medium containing STLC, 3MB-PP1, and/or MG132 for 2 h. Extracts were immunoprecipitated with antibodies to Cdc20 and resolved by 
SDS-PAGE. Levels of BubR1, APC8, Mad2, and Cdc20 in each IP were determined by quantitative immunoblotting. The ratio of each protein to Cdc20 was 
computed and normalized to ratios obtained from STLC-treated Mps1
wt cells (= 1.0). (B) Extracts were analyzed as in A except that Mad2 antibodies 
were used for IP, and Mad1 antibodies were also used for immunoblotting. (C) Cells were arrested in M phase via overnight treatment with nocodazole. 
At time 0, cells were either treated with 3MB-PP1 or left untreated as a control. Samples were collected at 30-min intervals for analysis of cyclin B levels (left)   
and determination of mitotic indices (right). Black lines indicate that intervening lanes have been spliced out. Error bars indicate SEM.95 Mps1 assembles Cdc20 inhibitory complexes • Maciejowski et al.
observations  have  led  to  newer  models  in  which  Mad2   
and/or  BubR1  can  be  activated  away  from  kinetochores.   
Indeed, Mad2 and BubR1 can spontaneously form a potent 
APC/C
Cdc20 inhibitor in vitro from purified proteins (Kulukian 
et al., 2009), which could, in theory, account for the cytosolic 
assembly of Cdc20 inhibitory complexes during interphase 
(Sudakin et al., 2001; Malureanu et al., 2009). However, our 
data reveal that such complexes cannot be formed or main-
tained in the absence of Mps1 kinase activity. Consequently, 
Mps1-inhibited cells progressed from NEB to anaphase onset 
in just 12 min, a time frame similar to the delay between Cdk1 
and APC/C
Cdc20 activation in cycling Xenopus egg extracts 
(Pomerening et al., 2005).
How  might  Mps1  promote  the  cytosolic  formation  of 
Cdc20 inhibitory complexes? Quantitative models of the SAC 
indicate that the rate at which a single unattached kinetochore 
generates Mad2–Cdc20 heterodimers is too slow to account for 
the global suppression of APC/C
Cdc20 activity under these condi-
tions (Ciliberto and Shah, 2009). Rather, this high degree of 
sensitivity requires further rounds of Mad2–Cdc20 complex 
assembly in the cytoplasm (De Antoni et al., 2005). We specu-
late that Mps1 activates this cytosolic amplification mecha-
nism either by phosphorylating soluble Mad2 or Mad2–Cdc20 
complexes directly (Wassmann et al., 2003) or by suppressing 
p31
comet, a structural mimic of Mad2 that competitively destabi-
lizes Mad2–Cdc20 complexes (Xia et al., 2004; Vink et al., 2006;   
targeting Bub1 to kinetochores (Fig. 8 B) but not for assembling 
Cdc20–Mad2 complexes (Fig. 8 C). Interestingly, Mps1
N not 
only rescued the accelerated mitosis seen in Mps1
as cells, but 
actually prolonged it in a 3MB-PP1–dependent manner (Fig. 8 D), 
suggesting that this cytosolic kinase can respond to (but not cor-
rect) biorientation defects caused by inhibition of kinetochore-
bound  Mps1
as.  As  a  direct  test  of  SAC  proficiency,  we 
quantified the duration of M phase in each cell line upon treat-
ment with nocodazole (Fig. 8 E). Although Mps1
as cells com-
pleted mitosis in 23 ± 5 min, Mps1
as/N cells remained in   
M phase for 742 ± 80 min or roughly half as long as Mps1
as/wt 
cells (1,419 ± 95 min; Fig. 8 E). These data establish that Mps1 
can indeed delay anaphase without being targeted to kineto-
chores. Nevertheless, its targeting substantially increases the 
perdurance of this delay. Thus, Mps1 uses both soluble and   
kinetochore-dependent mechanisms to generate and maintain 
the wait anaphase signal.
Discussion
Classically, the SAC has been conceptualized as a sensor of 
kinetochore–MT attachment defects. However, recent stud-
ies have painted a more complex picture, as the terminal ana-
phase inhibitors Mad2 and BubR1 (but not other canonical 
SAC components or kinetochores themselves) are also re-
quired to sustain basal M phase timing. These and related 
Figure  6.  Mps1  promotes  chromosome  bi-
orientation independently of aurora B. (A) Cells 
of the indicated genotypes were treated with 
3MB-PP1  and  MG132  for  1  h,  fixed,  and 
stained to detect centromeres (CREST; green), 
spindle MTs (-tubulin; red), and chromosomes 
(DAPI; blue). (B) Mitotic Mps1
wt and Mps1
as 
cells  were  collected  via  STLC  treatment  and 
shake  off  and  maintained  in  the  presence 
of STLC, MG132, and/or 3MB-PP1 for 2 h.   
Lysates  were  resolved  by  SDS-PAGE  and 
quantitative immunoblotting. The ratio of phos-
phorylated  histone  H3  (pH3)  to  tubulin  was 
computed  for  each  lane  and  normalized  to 
the ratio in STLC-treated Mps1
wt cells. (C) Cells 
were treated with nocodazole (noc) for 4 h to   
activate  the  SAC  and  treated  for  an  addi-
tional 4 h with nocodazole, MG132, and/or   
3MB-PP1. Centromeres (CREST) and serine 
7–phosphorylated  CENP-A  (pCENP-A)  were 
detected by immunofluorescence microscopy.   
(D) Quantification of results in C is shown. At 
least 100 centromeres in at least five cells were 
scored per sample. Error bars indicate SD. 
(E) MPS1
flox/ cells were infected with Adgal 
(top) or AdCre (bottom). 3 d later, both popula-
tions were treated with STLC and MG132 for 
30 min, fixed, and stained with the indicated 
antibodies. BubR1 loss from kinetochores was 
used as a functional marker of Mps1 inactiva-
tion (Fig. 7). Bars, 10 µm.JCB • VOLUME 190 • NUMBER 1 • 2010   96
from human cells using RNAi (Stucke et al., 2002; Liu et al., 
2003, 2006; Jelluma et al., 2008; Tighe et al., 2008). Two obser-
vations argue that this difference reflects more complete inacti-
vation  of  Mps1  using  gene  deletion  and  chemical  genetics, 
rather than an off-target effect on other kinases or ATPases. 
First and foremost, Mps1
wt cells were treated in the same man-
ner as Mps1
as cells and proved to be completely resistant to 
3MB-PP1 in all assays. Second, the epistasis pattern exposed   
by Mps1 inhibition in human cells mirrors those defined by or-
thogonal methods in other model systems (i.e., immunodeple-
tion in Xenopus egg extracts and strong Mps1 overproduction in 
budding yeast; Hardwick et al., 1996; Vigneron et al., 2004; 
Wong and Fang, 2005). This concurrence suggests that Mps1’s 
Yang et al., 2007). This would also explain why a cytosolic form 
of the kinase (Mps1
N) was able to restore Mad2–Cdc20 bind-
ing and inhibit anaphase onset in Mps1
as cells (Fig. 8). Never-
theless, long-term maintenance of this inhibition (e.g., during 
chronic treatment with spindle poisons) depends on Mps1’s tar-
geting to kinetochores, which presumably aids Mps1’s phos-
phorylation of docking partners and/or activators of Bub1 and 
other SAC mediators. In support of this view, cytosolic versions 
of Bub1 only partially rescue the SAC deficiency and chromo-
some misalignment phenotypes of Bub1 RNAi cells (Kiyomitsu 
et al., 2007; Klebig et al., 2009).
Many of the functions of Mps1 elucidated in this study 
were inapparent when this kinase was strongly (>90%) depleted 
Figure  7.  Mps1  kinase  activity  is  continu-
ously required to maintain Bub1 and all other 
SAC  effectors  at  unattached  kinetochores.  
(A and B) Mps1
wt and Mps1
as cells were treated 
with nocodazole for 4 h to activate the SAC 
and treated with nocodazole, MG132, and/or 
3MB-PP1 for an additional 2 h. Cells were 
fixed and stained with antibodies against the 
indicated  SAC  or  kinetochore  components 
(green)  and  CREST  antiserum  (red).  Note 
that cells not treated with 3MB-PP1 retained 
normal kinetochore localization patterns and, 
thus, have been omitted from these montages 
for  clarity.  Additional  kinetochore/centromere   
proteins  analyzed  in  this  assay  are  shown   
in Fig. S2. (C) Kinetochore (KT)-specific sig-
nal intensities were determined in 3MB-PP1– 
treated  Mps1
as  and  Mps1
wt  cells  (>100   
kinetochores  in  more  than  five  cells  per   
sample) and normalized to the equivalent values 
in untreated Mps1
wt cells. Error bars indicate 
SEM. Bars, 10 µm.97 Mps1 assembles Cdc20 inhibitory complexes • Maciejowski et al.
for proper alignment of chromosomes at the metaphase plate 
(Jelluma  et  al.,  2008).  Although  maloriented  chromosomes 
were frequently observed in Mps1-inhibited cells, we failed to 
detect any significant decrease in the phosphorylation of histone 
proximal targets and their mode of regulation by phosphoryla-
tion are likely to be conserved among all eukaryotes.
It was recently reported that Mps1 is needed to sustain 
normal levels of aurora B kinase activity and, thus, is required 
Figure 8.  Cytosolic-specific rescue of Mps1 inhibition restores mitotic timing and SAC proficiency to human cells. (A) Cells were fixed and stained with 
antibodies to centromere autoantigens (CREST; red) and transgene-encoded Mps1
wt and Mps1
N (green). (B) Mps1
as, Mps1
as/wt, and Mps1
as/N cells were 
treated with nocodazole for 4 h to activate the SAC and treated with nocodazole, MG132, and/or 3MB-PP1 for an additional 2 h. Cells were fixed and 
stained with antibodies against Bub1 (green) and CREST antiserum (red). Kinetochore (KT)-specific signal intensities were determined in 3MB-PP1–treated 
Mps1
as, Mps1
as/wt, and Mps1
as/N cells (>100 kinetochores in more than five cells per sample) and normalized to values in untreated Mps1
as cells. Bar, 
10 µm. (C) Mitotic cells were harvested by overnight STLC treatment and shake off and incubated in medium containing STLC, 3MB-PP1, and/or MG132 
for 2 h. Extracts and Cdc20 immunoprecipitates were analyzed as in Fig. 5. Recovery of Mad2 relative to Cdc20 was determined and normalized to 
its recovery from STLC- and MG132-treated Mps1
as cells (= 1.0). Black lines indicate that intervening lanes have been spliced out. (D) Quantification of 
mitotic timing is shown. Cumulative frequency of anaphase onset is plotted as a function of time after NEB. (E) Mps1
N rescues the SAC. Cells were traced 
by phase-contrast microscopy during treatment with nocodazole ± 3MB-PP1 (compare with Fig. 1 F). Error bars indicate SEM.JCB • VOLUME 190 • NUMBER 1 • 2010   98
strategy was used to create the pAAV-MPS1
 construct used to delete the 
second allele in MPS1
flox/+ cells. Procedures for preparation of infectious 
AAV particles, transduction of hTERT-RPE1 cells, and isolation of properly 
targeted clones have been described previously (Berdougo et al., 2009).
For retroviral transduction, inserts were cloned into pQCXIN and 
pQCXIB (Takara Bio Inc.), and the resulting plasmids were cotransfected 
with a vesicular stomatitis virus glycoprotein envelope expression construct 
into Phoenix cells. Infectious supernatants were collected, diluted 1:1 with 
complete medium containing 20 µg/ml Polybrene, and applied to target 
cells for 12 h. Selection with 0.4 mg/ml G418 or 5 µg/ml blasticidin was 
initiated 48 h later.
Antibodies, flow cytometry, immunofluorescence microscopy,  
and time-lapse imaging
A list of all antibodies used in this study is shown in Table S1. For flow   
cytometry, cells were fixed in 70% ethanol at 20°C for 24 h. Afterward, 
cells were rehydrated, blocked in 1% fetal calf serum in 0.1% Triton X-100 
and PBS, and stained with a mouse anti–MPM-2 antibody and an Alexa 
Fluor 633–conjugated anti–mouse secondary antibody (Invitrogen). For   
immunofluorescence microscopy, cells were plated onto chamber slides 
(LabTek; Sigma-Aldrich) and grown to 70% confluence. For all antigens ex-
cept cyclin B, cells were fixed in 4% PFA for 15 min and permeabilized in 
0.5% Triton X-100 for 5 min (protocol 1) or simultaneously fixed and per-
meabilized in 4% PFA and 0.2% Triton X-100 for 20 min (protocol 2), 
blocked in 3% BSA for 30 min, and incubated in primary antibody for 2 h 
at room temperature. For cyclin B (Fig. 4), cells were fixed in 20°C meth-
anol for 20 min and rehydrated in PBS for 5 min before blocking in 3% for 
30 min and incubation with primary antibody for 2 h at room temperature. 
Alexa Fluor 488–, 594–, and 647–conjugated goat antibodies were used 
for secondary detection. Cells were counterstained with DAPI before mount-
ing in Prolong Plus (Invitrogen). For time-lapse experiments, cells were grown 
on  6-well  plates  (for  phase-contrast  imaging)  or  35-mm  glass-bottomed 
dishes (for confocal imaging).
Widefield and phase-contrast images were acquired on an inverted 
microscope (TE2000; Nikon) equipped with 10× and 40× long–working 
distance and 100× oil objectives, single-bandpass excitation and emission 
filters,  a  camera  (ORCA  ER;  Hamamatsu  Photonics),  a  temperature- 
controlled stage enclosure with CO2 support (Solent Scientific), and NIS El-
ements software (Nikon). Spinning-disk microscopy (Fig. 2) was performed 
on a microscope (Axiovert 200; Carl Zeiss, Inc.) fitted with a confocal head 
(UltraView; PerkinElmer), a 512 × 512 EM charge-coupled device camera 
(iXon;  Andor),  XYZ  piezo  stage  (Prior  Scientific),  and  temperature- 
controlled enclosure with CO2 support (Solent Scientific). Imaging was per-
formed in normal growth media at 37°C. Acquisition was performed with 
MetaMorph (MDS Analytical Technologies). For deconvolution microscopy 
(Fig. 1 E and Fig. S2), an image restoration system (DeltaVision; Applied 
Precision) based on a microscope (IX-70; Olympus) with a 100× oil objec-
tive and a cooled charge-coupled device camera (CoolSnap QE; Photomet-
rics) was used. Calculations were performed using measured point-spread 
functions.  Individual  images  were  cropped  and  assembled  into  figures   
using PhotoShop (CS4; Adobe).
Extract preparation and IP
For analysis of mitotic Cdc20 inhibitory complexes, cells were arrested in 
STLC for 16 h, isolated by shake off, and plated in medium containing 
STLC, 3MB-PP1, and/or MG132 for 2 h. Cells were harvested, washed 
twice in ice-cold PBS, and snap frozen in a dry ice/methanol bath. For 
analysis  of  interphase  complexes,  cells  were  treated  with  3MB-PP1  or 
ZM447439 for 2 h, depleted of the mitotic fraction by shake off, and col-
lected by trypsin/EDTA treatment before snap freezing. Cell pellets were 
thawed on ice before resuspension in buffer B (140 mM NaCl, 30 mM 
Hepes, pH 7.8, 5% glycerol, 1 mM DTT, 0.2 µM microcystin, and 1× prote-
ase inhibitor cocktail [Sigma-Aldrich]) and disruption by nitrogen cavitation 
(1,250 psi for 45 min; Parr Instruments). Extracts were clarified by centrifu-
gation at 20,000 g for 30 min and quantified by assay (Bio-Rad Laborato-
ries). 2 mg mitotic extracts or 1 mg interphase extracts were used for each IP. 
In brief, extracts were incubated with mouse monoclonal antibody to Cdc20 
cross-linked to Dynabeads using BS
3 (Thermo Fisher Scientific). After 2 h, 
beads were washed four times in buffer B, resuspended in 1× Laemmli 
buffer, and boiled for 5 min to elute Cdc20 and any associated proteins.
Quantitative immunoblotting
SDS-PAGE resolved proteins were transferred to PVDF membranes and incu-
bated with primary antibodies as indicated in Table S1. Secondary antibodies 
(goat anti–rabbit IRDye 680 and goat anti–mouse IRDye 800CW) were used 
H3 or CENP-A, two well-known in vivo substrates of aurora B. 
One potentially relevant difference is that our analysis used   
human RPE cells (a nontransformed and chromosomally stable 
cell type), whereas the earlier study used U2OS cells, a cancer 
cell line that harbors multiple genetic alterations. Such altera-
tions might have disabled other regulatory networks that normally 
sustain aurora B activity independently of Mps1. Alternatively, 
because  the  RNAi  machinery  regulates  centromeric  hetero-
chromatin (Fukagawa, 2004), it is conceivable that high levels 
of some Mps1-directed shRNAs interfere with the processing of 
endogenous centromere-derived transcripts to produce subtle 
anomalies in inner centromere structure and function that mani-
fest as a synthetic defect in aurora B regulation. Consistent with 
our findings, two orthogonal Mps1 kinase inhibitors, AZ3146 
and reversine, also induce SAC override and chromosome biori-
entation defects without dampening aurora B activity in vivo 
(in this issue, see Hewitt et al., 2010; Santaguida et al., 2010).
In mammals, the SAC plays an essential role in suppressing 
aneuploidy, developmental anomalies, and malignancy (Weaver 
and Cleveland, 2009). Moreover, SAC signaling can either en-
hance or attenuate the ability of spindle poisons to kill cancer 
cells (Swanton et al., 2007; Gascoigne and Taylor, 2008; Janssen 
et al., 2009). Thus, understanding how the SAC operates in mo-
lecular terms remains an important objective with broad scien-
tific and medical relevance. Because the SAC itself is required 
for most methods of synchronizing cells in mitosis, biochemical 
analyses of SAC signaling require the development of specific 
and fast-acting inhibitors that can be applied to homogenous 
populations of mitotic cells. Although aurora B inhibitors can 
sometimes be used for this purpose, whether these compounds 
actually inactivate the SAC or merely lead to its satisfaction via 
stabilization of kinetochore–MT attachments remains contro-
versial (Ditchfield et al., 2003; Hauf et al., 2003; Pinsky and 
Biggins, 2005; Vanoosthuyse and Hardwick, 2009; Yang et al., 
2009). In contrast, Mps1 inhibition was effective in overriding the 
SAC even when MTs were depolymerized yet did not perturb 
phosphorylation of endogenous aurora B substrates. By enabling 
more surgical manipulation of the SAC, the tools developed in 
this study should clarify how this pathway and others interact to 
achieve high fidelity chromosome segregation in human cells.
Materials and methods
Cell culture and chemicals
All cell lines were maintained in the following media supplemented with 
10% fetal bovine serum and 100 U/ml penicillin/streptomycin: HEK293 
and Phoenix retroviral packaging lines, DME, hTERT-RPE1 cells, and a 1:1 
mixture  of  DME  and  Ham’s  F-12  medium  supplemented  with  2.5  mM   
L-glutamine. Where indicated, 200 ng/ml nocodazole (Sigma-Aldrich), 
100 µM monastrol (EMD), 5 µM STLC (Acros Organics), 10 µM 3MB-PP1 
(Burkard et al., 2007), 10 µM MG132 (Enzo Life Sciences, Inc.), and/or 
2 µM ZM (Tocris Bioscience) were added.
Molecular biology and retroviral transgenesis
To generate the MPS1
flox targeting construct, PfuTurbo polymerase (Agilent 
Technologies) was used to amplify left and right homology arms from bac-
teria artificial chromosome clone RP11-472L12. Both homology arms were 
cloned into pNY (Burkard et al., 2007; Terret et al., 2009), and a BglII-
marked loxP site was added via linker ligation. The entire targeting con-
struct  was  transferred  to  pAAV  as  an  NotI  fragment.  All  manipulated 
regions were checked by sequencing to ensure their integrity. A similar 99 Mps1 assembles Cdc20 inhibitory complexes • Maciejowski et al.
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